Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-17

FDA Approved: ALLERGY RELIEF — Original Application (CVS PHARMACY, INC)

View source ↗

Summary

FDA approves CVS Pharmacy, Inc.'s original ANDA for an allergy relief product containing fluticasone propionate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALLERGY RELIEF (cetirizine hydrochloride)

Snippet

ORIG AP for ALLERGY RELIEF (FLUTICASONE PROPIONATE)